BP (54677) Cord Blood America Form 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington D. C. 20549

______________

FORM 8-K

______________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)    October 3, 2005

______________

Cord Blood America, Inc.

(Exact name of registrant as specified in charter)

______________

Florida

000-50746

65-1078768

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)

9000 W. Sunset Boulevard, Suite 400, West Hollywood, CA  90069

(Address of principal executive offices)

(310) 432-4090

(Registrant’s Telephone Number, including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))







ITEM 7.01

Regulation FD Disclosure

On October 3, 2005, Cord Blood America, Inc. issued a press release announcing the Company has been featured in a webcast by Agora Investor Relations. The press release is attached hereto as Exhibit 99.26.

ITEM 8.01

Other Events

On October 3, 2005, Cord Blood America, Inc. issued a press release announcing the Company has been featured in a webcast by Agora Investor Relations. The press release is attached hereto as Exhibit 99.26.

ITEM 9.01

Financial Statements and Exhibits

(c)

Exhibits

99.26     Press Release dated October 3, 2005



2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

CORD BLOOD AMERICA, INC.

 

By:

/s/ Sandra D. Smith

  

Sandra D. Smith

  

Chief Financial Officer

Date:    October 3, 2005



3



EXHIBIT INDEX

Exhibit Number

 

Exhibit

 

99.26

     

Press Release dated October 3, 2005